New Challenges and Opportunities

There is a change most of the companies do their clinical trials in Asia. This challenge is not only for the global market but also the local market. There is a significant pharmaceutical market, and globally the market will be be #3 in 2011 and #2 in 2020. There is an increase in regulation requirements in clinical trials. It’s a regional opportunity. It’s significant to make the Pharma...